Hyaluronan in skin

Journal of Internal Medicine

Volumn 242, Issue 1, 1997, Pages 61-66

  Juhlin, L ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ageing; Cancer; Mucinosis; Psoriasis; Systemic sclerosis; Wound healing

Indexed keywords

DERMATAN SULFATE; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN;

AGING; BASAL CELL CARCINOMA; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; ECZEMA; FIBROMATOSIS; HUMAN; MELANOMA; MERKEL CELL TUMOR; MUCINOSIS; MYXEDEMA; NEUROFIBROMA; NONHUMAN; PREMATURE AGING; PRIORITY JOURNAL; PSORIASIS; SCLERODERMA; SKIN DISEASE; SQUAMOUS CELL CARCINOMA; SYSTEMIC SCLEROSIS; TISSUE REPAIR; TURNOVER TIME; WERNER SYNDROME; WOUND HEALING;

EID: 0030820093     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1997.00175.x     Document Type: Conference Paper

References (50)

1. Tammi R, Ågren UM, Tuhkanen A-L, Tammi M. Hyaluronan metabolism in skin. In: Progr Histochem Cytochem 1994; 29: 1-77. Stuttgart. New York: Gustav Fischer Verlag, 1994.
2. Tammi R, Paukkonen K, Wang C, Horsmanheimo M, Tammi M. Hyaluronan and CD44 in psoriatic skin. Intense staining for hyaluronan on dermal capillary loops and reduced expression of CD44 and hyaluronan in keratinocyte-leukocyte interfaces. Arch Dermatol Res 1994; 286: 21-9.
3. Laurent TC, Fraser JRE. Hyaluronan. FASEB J 1992; 6: 2397-404.
4. Meyer LJM, Stern R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol 1994; 102: 385-9.
5. Longaker MT, Chiu ES, Adzick NS, Stern M, Harrison MR, Stern R. Studies in fetal wound healing: V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surgery 1991; 215: 292-8.
6. Higuchi T, Ishikawa O, Hayashi H, Ohnishi K, Miyachi Y. Disaccharide analysis of the skin glycosaminoglycans in patients with Werner's syndrome. Clin Exp Dermatol 1994; 19: 487-91.
7. Nakamura T, Takagaki K, Kubo K, Saito T, Endo M, Mori S et al. Hyaluronate synthesized by cultured skin fibroblasts derived from patients with Werner's syndrome. Biochim Biophys Acta 1992; 1139: 84-90.
8. Konohana A, Miyakawa S, Tajima S, Nishikawa T. Decreased collagen and hyaluronic acid content in lesional skin of acrogeria. Dermatologica 1986; 172: 241-4.
9. Vries HJC de, Zeegelaar JE, Middelkoop E, Gijsbers G, Marie J van, Wildevuur CHR, Westerhof W. Reduced wound contraction and scar formation in punch biopsy wounds. Native collagen dermal substitutes. A clinical study. Br J Dermatol 1995; 132: 690-7.
10. Borgognoni L, Reali UM, Santucci M. Low molecular weight hyaluronic acid induces angiogenesis and modulation of the cellular infiltrate in primary and secondary healing wounds. Eur J Dermatol 1996; 6: 127-31.
11. Camp RL, Scheynius A, Johansson C, Puré E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 1993; 178: 497-507.
12. Poulsen JH, Cramers MK. Dermal glycosaminoglycans characterise the primary irritant dermatitis in psoriatics and healthy individuals. Clin Chem Acta 1983; 130: 305-15.
13. Juhlin L, Tengblad A, Ortonne JP, Lacour JP. Hyaluronate in suction blisters from patients with scleroderma and various skin disorders. Acta Derm Venereol (Stockh) 1986; 66: 409-13.
14. Levesque H, Baudot N, Delpech B, Vayssairat M, Gancel A, Lauret PH, Courtois H. Clinical correlation and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis. Br J Derm 1991; 124: 423-8.
15. Akimoto S, Hayashi H, Ishikawa H. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis. Br J Dermatol 1992; 126: 29-34.
16. Higuchi T, Ohnishi K, Hayashi H, Ishikawa O, Miyachi Y. Changes in skin disaccharide components correlate with the severity of sclerotic skin in systemic sclerosis. Acta Derm Venereol (Stockh) 1994; 74: 179-82.
17. Møller R, Serup J, Ammitzbøll T. Glycosaminoglycans in localized scleroderma (morphoea). Connect Tissue Res 1985; 13: 227-36.
18. Engström-Laurent A, Feltelius N, Hällgren R, Wasteson A. Raised serum hyaluronan levels in scleroderma: an effect of growth factor induced elevation of connective tissue cells. Ann Rheum Dis 1985; 44: 614-20.
19. Freitas JP, Filipe PI, Emerit I, Meunier P, Manso CF, Guerra Rodrigo F. Hyaluronic acid in progressive systemic sclerosis. Dermatol 1996; 192: 46-9.
20. Lundin Å, Engström-Laurent A, Hällgren R, Michaëlsson G. Circulating hyaluronate in psoriasis. Br J Dermatol 1985; 112: 663-71.
21. Lundin Å, Engström-Laurent A, Michaëlsson G, Tengblad A. High levels of hyaluronate in suction blister fluid from active psoriatic lesions. Br J Dermatol 1987; 116: 335-40.
22. Wells AF, Lundin Å, Michaëlsson G. Histochemical localization of hyaluronan in psoriasis, allergic contact dermatitis and normal skin. Acta Derm Venereol (Stockh) 1991; 71: 232-8.
23. McCourt PAG, Ek B, Forsberg N, Gustafson S. ICAM-1 is a cell-surface receptor for hyaluronan. J Biol Chem 1994; 269: 30081-4.
24. Gustafson S, Wikström T, Juhlin L. Histochemical studies of hyaluronan and the hyaluronan receptor ICAM-1 in psoriasis. Int J Tissue React 1995; 17: 167-73.
25. Horrocks C, Duncan JI, Oliver AM, Thomson AW. Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A. Clin Exp Immunol 1991; 84: 157-62.
26. Thomson AW, Nalesnik MA, Rilo HR, Woo J, Carroll PB, Van Thiel DH. ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity 1993; 15: 215-23.
27. Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 1987; 16: 409-15.
28. Shishiba Y, Imai Y, Odajima R, Ozawa Y, Shimizu T. Immunoglobulin G of patients with circumscribed pretibial myxedema of Graves' disease stimulates proteoglycan synthesis in human skin fibroblasts in culture. Acta Endocrinol 1992; 127: 44-51.
29. Taylor AL, Owen ET. Scleromyxoedema associated with synovitis and myopathy. Br J Rheumatol 1994; 33: 872-4.
30. Harper RA, Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science 1978; 199: 545-7.
31. Turakainen H, Välimäki M, Penttinen R. Synthesis of glycosaminoglycans and collagen in skin fibroblasts cultured from a patient with lichen myxedematosus. Arch Dermatol Res 1985; 277: 55-9.
32. Pandya AG, Sontheimer RD, Cockerel CJ, Takashima A, Piepkorn M. Papulonodular mucinosis associated with systemic lupus erythematosus: possible mechanisms of increased glycosaminoglycan accumulation. J Am Acad Dermatol 1995; 32: 199-205.
33. Braddock SW, Davis CS, Davis RB. Reticular erythematous mucinosis and thrombocytopenic purpura. Report of a case and review of the world literature, including plaque-like cutaneous mucinosis. J Am Acad Dermatol 1988; 19: 859-68.
34. Fleischmajer R, Lara JV, Scleredema. A histochemical and biochemical study. Arch Dermatol 1965; 92: 643-52.
35. Roupe G, Laurent TC, Malmström A, Suurküla M, Särnstrand B. Biochemical characterization and tissue distribution of the scleredema in a case of Buschke's disease. Acta Derm Venereol (Stockh) 1987; 67: 193-8.
36. Christy W, Buckingham RB, Barnes EL, Prince RK. Scleredema adultorum of Buschke: a clinical, pathologic, and cell culture study of two patients. J Rheumatol 1983; 10: 595-601.
37. Wells AF, Lundin Å, Michaëlsson G, Pontén F. Hyaluronan in basal cell carcinomas. Acta Derm Venereol (Stockh) 1991; 71: 274-5.
38. Yasaka N, Furue M, Tamaki K. CD44 expression in normal human skin and skin tumours. J Dermatol 1995; 22: 88-94.
39. Baum H-P, Schmid T, Schock G, Reichrath J. Expression of CD44 isoforms in basal cell carcinomas. Br J Dermatol 1996; 134: 465-8.
40. Salmi M, Grön-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: Down regulation during malignant transformation of tumours of squamocellular origin. J Cell Biol 1993; 122: 431-42.
41. Turley EA, Tretiak M. Glycosaminoglycan production by murine melanoma variants in vivo and in vitro. Cancer Res 1985; 45: 5098-105.
42. Edward M, Grant AW, Mackie RM. Human melanoma cell-derived factor(s) stimulate fibroblast glycosaminoglycan synthesis. Int J Cancer 1992; 52: 499-503.
43. Thomas L, Etoh T, Stamenkovic I, Mihm MC, Byers HR. Migration of humn melanoma cells on hyaluronate is related to CD44 expression. J Invest Dermatol 1993; 100: 115-20.
44. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB. A cell surface chondroitin sulfate proteoglycan. immunologically related to CD44, is involved in type-I collagen-mediated melanoma cell motility and invasion. J Cell Biol 1992; 116: 521-31.
45. Manten-Horst E, Danen EH, Smit L, Snoek M, Le Poole IC, van Muijen GN et al. Expression of CD44 splice variants in human cutaneous melanoma and melanoma cell lines is related to tumour progression and mutastatic potential. Int J Cancer 1995; 64: 182-8.
46. Mayer-da-Silva A, Poiares-Baptista A, Guerra Rodrigo F, Teresa-Lopes M. Juvenile hyaline fibromatosis. A histologic and histochemical study. Arch Pathol Lab Med 1988; 112: 928-31.
47. Penneys NS, Shapiro S. CD44 expression in Merkel cell carcinoma may correlate with risk of metastasis. J Cutan Pathol 1994; 21: 22-6.
48. Banerjee SS, Eyden BP, Wells S, McWilliam LJ, Harris M. Pseudoangiosarcomatous carcinoma: a clinicopathological study of seven cases. Histopathology 1992; 21: 13-23.
49. Sasaki T, Onodera S. Glycosaminoglycans in neurofibromas. J Dermatol 1990; 17: 653-60.
50. Martelli H, Richard S, Moczar M, Godeau G, Pfister A, Pellerin D, Vekemans M. Congenital soft tissue dysplasias: a morphological and biochemical study. Ped Pathol 1994; 14: 873-94.